Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer potential implications for treatment choices

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 2, 2009, Pages 180-188

  Lohavanichbutr, Pawadee ^a   Houck, John ^a   Fan, Wenhong ^a   Yueh, Bevan ^b   Mendez, Eduardo ^a,c,d   Futran, Neal ^d   Doody, David R ^a   Upton, Melissa P ^e   Farwell, D Gregory ^f   Schwartz, Stephen M ^a,e   Zhao, Lue Ping ^a   Chen, Chu ^a,d,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DETERMINATION; DNA REPAIR; DNA REPLICATION; FEMALE; GENE EXPRESSION PROFILING; GENOME; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CAVITY; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; PREVALENCE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; UNITED STATES; VIRUS DETECTION; WART VIRUS;

AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE;

EID: 60849085709     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2008.540     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32(suppl 1):S59-S66.
3. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90(21):1626-1636.
4. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344 (15):1125-1129.
5. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96 (6):449-455.
6. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillo-mavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-1956.
7. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. JNatlCan-cerInst. 2000;92(9):709-720.
8. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104(3):336-344.
9. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell carcinoma: a population based study. Otolaryngol Head Neck Surg. 2001;125(1):1-9.
10. Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004;112(6):1015-1019.
11. Sotlar K, Diemer D, Dethleffs A, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004;42(7):3176-3184.
12. Xu XL, Olson JM, Zhao LP. A regression-based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington's disease transgenic model. Hum Mol Genet. 2002;11(17):1977-1985.
13. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-475.
14. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-350.
15. Kingsley K, Johnson D, O'Malley S. Transfection of oral squamous cell carcinoma with human papillomavirus-16 induces proliferative and morphological changes in vitro. Cancer Cell Int. 2006;6:14.
16. Yde CW, IssingerOG. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. Int J Oncol. 2006;29(6):1397-1404.
17. Huang H, Huang SY, Chen TT, Chen JC, Chiou CL, Huang TM. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16E6 containing SiHa cells. J Cell Biochem. 2004;91(4):756-765.
18. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330-338.
19. Alli E, Bash-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res. 2002;62(23):6864-6869.
20. Alli E, Yang JM, Ford JM, Hait WN. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol. 2007;71(5):1233-1240.
21. Johnsen JI, Aurelio ON, KwajaZ, et al. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int J Cancer. 2000;88(5):685-691.
22. Torres-Roca JF, Eschrich S, Zhao H, et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res. 2005;65(16):7169-7176.
23. Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(3, pt 1):701-709.
24. Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squa-mous cell carcinomas. Eur J Cancer. 2007;43(2):415-432.